META
Meta Platforms, Inc.
META offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
OPRA
Opera Limited
OPRA has the edge over META overall, supported by stronger fundamentals and stronger modeled upside.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
OPRA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
OPRA's revenue, profitability, cash flow and balance sheet are all currently healthy.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over OPRA in the historical PE scenario, which offers more potential upside but is not a forecast.
OPRA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $10.24 | -35% |
| Current | 11x | $15.63 | — |
| Fair | 16x | $22.42 | +43% |
| Expensive | 28x | $38.34 | +145% |
Historical ranges are pointers, not guarantees.
OPRA's PE is in its cheap range at 11x, but its recent earnings include one-off gains.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
OPRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
OPRA has the edge over META on the outlook, with more favorable profitability expectations.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over OPRA on earnings, with more consistent year-over-year improvement.
OPRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.38 | +55% |
| Q1 2026 | $1.25 | +33% |
| Q4 2025 | $1.18 | +30% |
| Q4 2025 | $0.89 | -55% |
| Q2 2025 | $0.89 | -54% |
| Q1 2025 | $0.94 | -50% |
| Q4 2024 | $0.91 | -52% |
| Q3 2024 | $1.97 | +170% |
OPRA's earnings per share have fallen from their peak: $1.38 over the past year, against $1.97 in late 2024. Its recent earnings include one-off gains.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over OPRA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over OPRA on profitability, with a higher operating margin.
OPRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $177.5M | +24% |
| Q1 2026 | $175.8M | +23% |
| Q4 2025 | $177M | +21% |
| Q4 2025 | $151.9M | +23% |
| Q2 2025 | $143M | +30% |
| Q1 2025 | $142.7M | +40% |
| Q4 2024 | $145.8M | +29% |
| Q3 2024 | $123.2M | +20% |
OPRA's revenue has grown year over year for 22 quarters in a row: $177M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | +3.7 points |
| Q1 2026 | 17% | +2.5 points |
| Q4 2025 | 17% | -2.3 points |
| Q4 2025 | 15% | -4.1 points |
| Q2 2025 | 13% | -7.3 points |
| Q1 2025 | 15% | -4.4 points |
| Q4 2024 | 19% | +0.9 points |
| Q3 2024 | 19% | +3.2 points |
OPRA's operating margin was 16% last quarter, up 3.7 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
OPRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $21.8M | -28% |
| Q1 2026 | $36.8M | +140% |
| Q4 2025 | $39.6M | +101% |
| Q4 2025 | $22.5M | -27% |
| Q2 2025 | $30.3M | +109% |
| Q1 2025 | $15.3M | +42% |
| Q4 2024 | $19.7M | -20% |
| Q3 2024 | $30.8M | +93% |
OPRA has the edge over META on cash flow, with more consistent year-over-year improvement.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over OPRA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
OPRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -67K shares |
| 1 year | +0.8% | +760K shares |
| 3 years | -0.3% | -237K shares |
| 5 years | -21% | -24.7M shares |
| Available history | -19% | -21.9M shares |
OPRA has 91M diluted shares, up 0.8% from a year ago, despite $27M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $14.2M |
| Q1 2026 | $12.8M |
| Q4 2025 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OPRA spent $27M buying back its own shares over the past year, after none the year before.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
OPRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
| Q3 2024 | -1.0x | Net Cash |
OPRA has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
OPRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 9.3 | Oversold |
OPRA's weekly RSI is 40 (neutral) and its Stochastic is 9 (oversold).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
OPRA PE vs Communication Services Sector
| Metric | OPRA | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 16x | 31% below |
| PE % | 25 | 26 | 1 pt below |
OPRA has the edge over META on valuation relative to its sector.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
OPRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.7 | 6.6% below |
| 20 week MA | $18.2 | 14% below |
| 50 week MA | $16.6 | 5.6% below |
| 100 week MA | $16.9 | 7.6% below |
| 200 week MA | $15.3 | 2.4% above |
OPRA has fallen below most of its moving averages, though it's still 2.4% above its 200-week average.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.
OPRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.44 | $8.49 | -10% |
| 2021 | $8.49 | $7.19 | -15% |
| 2022 | $7.19 | $5.98 | -17% |
| 2023 | $5.98 | $13.2 | +121% |
| 2024 | $13.2 | $19.0 | +43% |
| 2025 | $19.0 | $14.5 | -24% |
| 2026 YTD | $14.5 | $15.6 | +7.7% |
OPRA has the edge over META on returns for 2026, with the stronger performance.